Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.
Burak, Furkan, Karen E Inouye, Ariel White, Alexandra Lee, Gurol Tuncman, Ediz S Calay, Motohiro Sekiya, et al. 2015. “Development of a Therapeutic Monoclonal Antibody That Targets Secreted Fatty Acid-Binding Protein AP2 to Treat Type 2 Diabetes.”. Science Translational Medicine 7 (319): 319ra205.